Dihexa
Mechanism
A small-molecule angiotensin IV analogue (N-hexanoic-Tyr-Ile-(6) amino-hexanoic amide). Enhances hepatocyte growth factor (HGF) signalling and promotes synaptogenesis. Reported to be ~10 million times more potent than BDNF in some assays. Limited human data.
Typical dose
8-15mg per day oral (limited human protocols).
Cycle length
4-6 weeks experimental cycles
Form
Oral capsules, transdermal cream
